2023
DOI: 10.2174/0929866530666230607104453
|View full text |Cite
|
Sign up to set email alerts
|

Applications of CRISPR Cas-9 in Ovarian Cancer Research

Abstract: Ovarian cancer is a highly prevalent malignancy among women and affects a significant population worldwide. Different forms of hormonal treatments or chemotherapies are used to treat ovarian cancer, but the possible side effects, including menopausal symptoms, can be severe, forcing some patients to prematurely stop the treatment. The emerging genome editing technology, known as clustered regularly interspaced short palindromic repeats (CRISPR)-caspase 9 (Cas9), has the potential to treat ovarian cancer via ge… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 93 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?